BELGRADE, Mont., Aug. 30 /PRNewswire-FirstCall/ -- Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) (“Bacterin”), announced todaythat it is scheduled to present at the upcoming Rodman & Renshaw Annual Global Investment Conference Healthcare Track on Wednesday, September 15, 2010, at 10:00 a.m.(ET) at the New York Palace Hotel in New York City. Guy Cook, founder, president and CEO of Bacterin, and John Gandolfo, CFO will present the Company’s operations and its strategic positioning. Bacterin, founded in 1999 and based in the nation’s research center for biofilm engineering, is a developer of unique, anti-infective coatings for medical applications and a producer of revolutionary scaffolds for tissue regeneration.
The presentation will be broadcast live over the Internet and can be accessed at http://www.wsw.com/webcast/rrshq18/bihi.ob/ or through the Company’s website at www.bacterin.com.
About Bacterin International Holdings, Inc.
BACTERIN INTERNATIONAL HOLDINGS, INC. (“Bacterin”) develops, manufactures and markets biologics products to domestic and international markets. Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone defect repair in articulating joint surgeries.
Bacterin’s Medical Device division develops anti-microbial coatings based upon proprietary coating technologies. Bacterin develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin’s strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination on medical devices drug delivery, local (as opposed to systemic) pain management, and anti-thrombotic factors for medical device applications.
Headquartered in Belgrade, Montana, Bacterin operates a 32,000 square foot., state-of-the-art, fully compliant and FDA registered facility, equipped with five “Class 100" clean rooms. For further information please visit www.bacterin.com
About Rodman & Renshaw Capital Group, Inc.
Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.
Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant capital needs, along with research and sales and trading services to investor clients that focus on such companies. Rodman is a leading investment banking firm with particular emphasis on industries with significant capital needs, including health care, energy, and metals/mining, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Risk factors are listed in the most recent 8-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.
SOURCE Bacterin International Holdings, Inc.
